Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

Specimen Handling 134pembrolizumab 123Magnetic Resonance Spectroscopy 112Carboplatin 88Cyclophosphamide 82Biopsy 75Cisplatin 61Bevacizumab 59Paclitaxel 58Gemcitabine 57Nivolumab 53fludarabine 46Rituximab 41atezolizumab 39Pemetrexed 38Fluorouracil 38Docetaxel 38Dexamethasone 38Doxorubicin 35Radiotherapy 33Leucovorin 33Capecitabine 33venetoclax 32Prednisone 32Oxaliplatin 31Temozolomide 30130-nm albumin-bound paclitaxel 29Standard of Care 27Cetuximab 27durvalumab 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Laryngectomy × 30 days × Clear all
NCT07392580 2026-06-01

Intralesional Chemotherapy (IC): Cisplatin + Epinephrine

University of Miami

Phase 2 Recruiting
20 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡